EMOVERE MARRIAGE AND FAMILY THERAPY Trademark

Trademark Overview


On Thursday, April 25, 2024, a trademark application was filed for EMOVERE MARRIAGE AND FAMILY THERAPY with the United States Patent and Trademark Office. The USPTO has given the EMOVERE MARRIAGE AND FAMILY THERAPY trademark a serial number of 98519173. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, November 14, 2024. This trademark is owned by Emovere Marriage and Family Therapy PLLC. The EMOVERE MARRIAGE AND FAMILY THERAPY trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Mental health therapy services

General Information


Serial Number98519173
Word MarkEMOVERE MARRIAGE AND FAMILY THERAPY
Filing DateThursday, April 25, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, November 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2024

Trademark Statements


Goods and ServicesMental health therapy services
NOT AVAILABLE"Marriage and Family Therapy"

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 25, 2024
Primary Code044
First Use Anywhere DateMonday, April 1, 2024
First Use In Commerce DateMonday, April 1, 2024

Trademark Owner History


Party NameEmovere Marriage and Family Therapy PLLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRaleigh, NC 27609

Trademark Events


Event DateEvent Description
Thursday, April 25, 2024NEW APPLICATION ENTERED
Thursday, October 17, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, November 10, 2024ASSIGNED TO EXAMINER